Table 2.

Patients with HCC included before treatment

Patient ID	Age, years	Sex	Interpretation of FDGal PET images	Interpretation of ceCT images	Other imaging modalities or follow-up	T/B-ratio on FDGal PET
1	71	F	Multinodular disease	Multinodular disease		1.6
3	61	M	Multinodular disease	Multinodular disease		1.6
4	52	M	Multinodular disease	Multinodular disease		2.0
5	73	M	Multinodular disease	Multinodular disease		1.7
6	48	M	Several suspicious nodules	Four nodules	Rapid progression to multinodular	1.3
7	70	F	Multinodular disease	Multinodular disease		1.4
8	50	M	Two lesions	Several dense areas, one suspicious	US: two lesions	Both 1.2
9	71	M	One lesion in right lobe, one suspicious in left lobe	One lesion in left liver lobe	US: one lesion	Both 1.4
10	40	F	Multinodular disease	Multinodular disease		1.8
12	71	M	Necrotic tumour	Necrotic/hypoperfused		0.8
15	69	F	Necrotic tumour	Necrotic tumour		0.7
17	64	M	Multinodular disease	Multinodular disease	US: one minor lesion	1.4 – 1.8
19	64	M	Multinodular disease with necrotic areas	Multinodular disease with necrotic areas		1.3 (viable) 0.4 (necrosis)
20	49	M	Multinodular disease	One small suspicious lesion	US: no lesions Died 7 weeks later (multinodular HCC)	1.4
21	51	M	Large necrotic tumour	Large necrotic tumour	US: two lesions	0.3
22	77	M	Large tumour with central necrosis	Lager tumour with central necrosis		1.5 (viable) 0.3 (necrosis)
24	86	F	Two lesions	One lesion	Progression in PET positive areas	1.7; 1.3
27	59	M	Three distinct lesions	No lesions	MRI: one lesion, biopsy positive Follow-up: several lesions on US	1.4 – 1.8
28	73	F	No lesions	One lesion	US: one lesion, biopsy-positive	n.d.
32	61	M	Multinodular disease	Multinodular disease	US: Multinodular	1.3 – 2.8
33	63	M	Three lesions	Three lesions	US: two lesions	1.6 – 1.9
35	78	F	Large necrotic tumour	Large necrotic tumour		0.6
36	85	M	Large necrotic tumour	Large necrotic tumour		0.2

FDGal, 2-[¹⁸F]fluoro-2-deoxy-d-galactose; ceCT, contrast-enhanced CT; T/B-ratio, tumour-to-background ratio; F, female; M, male; US, ultrasound sonography; MRI, magnetic resonance imaging; n.d., not determined.